Skip to main content

Advertisement

Log in

Benefits of weight loss programs for breast cancer survivors: a systematic reviews and meta-analysis of randomized controlled trials

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Obesity and weight gain have been associated with poor disease-specific and health-related outcomes in breast cancer survivors (BCS). But the benefits of weight loss in managing BCS have not been elucidated.

Objective

To evaluate the beneficial effects of weight loss programs in randomized controlled trials on BCS.

Methods

We searched English databases PubMed, the Cochrane Library, EMBASE, Scopus, Web of Science, CINAHL, and Chinese databases China National Knowledge Infrastructure (CNKI), Weipu Information Chinese Periodical Service Platform (VIP), China Biomedical Literature Service System (SinoMed), and Wanfang from the inception to January 2021 and collected randomized controlled trials (RCTs) of weight loss programs for BCS. Two reviewers independently screened the literature, extracted the data, and assessed the risk of bias in the included studies. The data synthesis was performed on RevMan (version 5.3), and the publication bias was calculated with STATA (version 15.1).

Results

Ten RCTs were included in the meta-analysis. The current study showed that diet and exercise interventions resulted in significant improvements in body weight (MD =  − 4.43 kg, 95%CI: − 6.23 to − 2.63, P < 0.00001), waist circumference (MD =  − 2.81 cm, 95%CI: − 4.37 to − 1.26, P = 0.004), hip circumference (MD =  − 3.01 cm, 95%CI: − 4.24 to − 1.77, P < 0.0001), body mass index (MD =  − 1.69 kg/m2, 95%CI: − 2.16 to − 1.21, P < 0.00001), systolic blood pressure (MD =  − 12.12 mmHg, 95%CI: − 18.97 to − 5.27), p = 0.0005), C-reactive protein (MD =  − 1.83 mg/L, 95% CI: − 2.74 to − 0.91, p < 0.0001), body fat (MD =  − 1.19 kg, 95%CI: − 1.75 to − 0.63, P < 0.001), fat mass (MD =  − 2.29 kg, 95%CI: − 3.12 to − 1.46, P < 0.0001), and lean body mass (MD =  − 2.15 kg, 95%CI: − 3.66 to − 0.65, P = 0.005). Alternatively, compared with the effects of control interventions, weight loss programs did not affect fat-free mass, total cholesterol, low-density leptin cholesterol, glucose, insulin, and leptin (P > 0.05).

Conclusions

This review summarizes the benefits of weight loss programs for BCS. The results indicated that weight loss programs could significantly improve specific anthropometric outcomes but not affect biochemical indicators. Researchers should tailor weight loss interventions to the body fat status of BCS. Evidence to support the translation of effective weight loss intervention programs into wider-scale implementation is needed to be part of routine survivorship care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its supplementary information files.

Abbreviations

BCS:

Breast cancer survivors

MD:

Mean difference

SMD:

Standardized mean difference

95% CI:

95% Confidence interval

RCTs:

Randomized controlled trials

BMI:

Body mass index

SBP:

Systolic blood pressure

CRP:

C-reactive protein

LDL-C:

Low-density leptin cholesterol

TC:

Total cholesterol

References

  1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Makari-Judson G, Braun B, Jerry DJ et al (2014) Weight gain following breast cancer diagnosis: implication and proposed mechanisms. World J Clin Oncol 5(3):272–282. https://doi.org/10.5306/wjco.v5.i3.272

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sedjo RL, Byers T, Ganz PA et al (2014) Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors. J Cancer Surviv 8(3):410–418. https://doi.org/10.1007/s11764-014-0351-9

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vagenas D, DiSipio T, Battistutta D, et al. Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study. BMC Cancer. 2015;15:28. Published 2015 Jan 31. https://doi.org/10.1186/s12885-015-1026-2

  5. Kim A, Scharf K, Senthil M et al (2014) The prevalence of overweight and obesity in a breast clinic population: consideration for weight loss as a therapeutic intervention. Surgery for Obesity and Related Diseases 10(2):348–353. https://doi.org/10.1016/j.soard.2013.07.019

    Article  PubMed  Google Scholar 

  6. Imayama I, Alfano CM, Neuhouser ML et al (2013) Weight, inflammation, cancer-related symptoms and health-related quality of life among breast cancer survivors. Breast Cancer Res Treat 140(1):159–176. https://doi.org/10.1007/s10549-013-2594-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Demark-Wahnefried W, Campbell KL, Hayes SC (2012) Weight management and its role in breast cancer rehabilitation. Cancer 118:2277–2287. https://doi.org/10.1002/cncr.27466

    Article  PubMed  Google Scholar 

  8. Vance V, Mourtzakis M, McCargar L et al (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12(4):282–294. https://doi.org/10.1111/j.1467-789X.2010.00805.x

    Article  CAS  PubMed  Google Scholar 

  9. Bradshaw PT, Ibrahim JG, Stevens J et al (2012) Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology 23(2):320–327. https://doi.org/10.1097/EDE.0b013e31824596a1

    Article  PubMed  PubMed Central  Google Scholar 

  10. Caan BJ, Kwan ML, Shu XO et al (2012) Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomark Prev 21(8):1260–1271. https://doi.org/10.1158/1055-9965.Epi-12-0306

    Article  Google Scholar 

  11. Norman JE, Bild D, Lewis CE et al (2003) The impact of weight change on cardiovascular disease risk factors in young black and white adults: the CARDIA study. Int J Obes 27(3):369–376. https://doi.org/10.1038/sj.ijo.0802243

    Article  CAS  Google Scholar 

  12. Truesdale KP, Stevens J, Lewis CE et al (2006) Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study. Int J Obes 30(9):1397–1407. https://doi.org/10.1038/sj.ijo.0803307

    Article  CAS  Google Scholar 

  13. Blanchard CM, Courneya KS, Stein K (2008) Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 26(13):2198–2204. https://doi.org/10.1200/jco.2007.14.6217

    Article  PubMed  Google Scholar 

  14. Hair BY, Hayes S, Tse CK et al (2014) Racial differences in physical activity among breast cancer survivors. Cancer 120(14):2174–2182. https://doi.org/10.1002/cncr.28630

    Article  PubMed  Google Scholar 

  15. Jiralerspong S, Kim ES, Dong W et al (2013) Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 24(10):2506–2514. https://doi.org/10.1093/annonc/mdt224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. World Cancer Research Fund/American Institute for Cancer Research (2009) Policy and action for cancer prevention: food, nutrition and physical activity, a global perspective. AICR, Washington, DC, p 4

    Google Scholar 

  17. Weaver KE, Foraker RE, Alfano CM et al (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7(2):253–261. https://doi.org/10.1007/s11764-013-0267-9

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors [published correction appears in CA Cancer J Clin. 2013 May;63(3):215]. CA Cancer J Clin. 2012;62(4):243–274. https://doi.org/10.3322/caac.21142

  19. Rosti G, Romano F, Secondino S, et al. The role of nutritional support in cured/chronic patients. Nutrients. 2020;12(10). https://doi.org/10.3390/nu12103167.

  20. Ligibel JA, Alfano CM, Courneya KS et al (2014) American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 32(31):3568–3574. https://doi.org/10.1200/JCO.2014.58.4680

    Article  PubMed  PubMed Central  Google Scholar 

  21. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/ July 15 2015.

  22. WHO Consultation on Obesity, Division of Noncommunicable Diseases, Programme of Nutrition, Family and Reproductive Health. Obesity preventing and managing the global epidemic: report of a WHO consultation on obesity, 3–5 June 1997. World Health Organization, Geneva, 1998. [http://apps.who.int/iris/handle/10665/63854]

  23. Włodarczyk M, Nowicka G. Obesity, DNA damage, and development of obesity-related diseases. Int J Mol Sci. 2019;20(5):1146. Published 2019 Mar 6. https://doi.org/10.3390/ijms20051146

  24. Khandekar MJ, Cohen P, Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 11(12):886–895. https://doi.org/10.1038/nrc3174

    Article  CAS  PubMed  Google Scholar 

  25. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20(1):42–51. https://doi.org/10.1200/jco.20.1.42

    Article  CAS  PubMed  Google Scholar 

  26. Irwin ML, Duggan C, Wang CY et al (2011) Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol 29(1):47–53. https://doi.org/10.1200/jco.2010.28.4752

    Article  CAS  PubMed  Google Scholar 

  27. World Cancer Research Fund. Be a healthy weight.www.wcrf.org/dietandcancer/recommendations/be-healthy-weight (accessed November 19 2019).

  28. Reeves MM, Terranova CO, Eakin EG et al (2014) Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev 15(9):749–768. https://doi.org/10.1111/obr.12190

    Article  CAS  PubMed  Google Scholar 

  29. Shaikh H, Bradhurst P, Ma LX, et al. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev. 2020;12:CD012110.  https://doi.org/10.1002/14651858.

  30. Office of Cancer Survivorship, NCI About cancer survivorship research: survivorship definitions. 2012. Available from: http:// cancercontrol.cancer.gov/ocs/researcher_factsheet.pdf

  31. Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.

  32. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.

  33. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Higgins JP, Thompson SG, Altman DJJ, DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  PubMed Central  Google Scholar 

  35. Harvie M, Pegington M, McMullan D et al (2019) The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial. Br J Cancer 121(6):443–454. https://doi.org/10.1038/s41416-019-0522-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ferrante JM, Devine KA, Bator A et al (2018) Feasibility and potential efficacy of commercial mHealth/eHealth tools for weight loss in African American breast cancer survivors: pilot randomized controlled trial. Translational behavioral medicine. https://doi.org/10.1093/tbm/iby124

    Article  PubMed  PubMed Central  Google Scholar 

  37. Arikawa AY, Kaufman BC, Raatz SK, et al. Effects of a parallel-arm randomized controlled weight loss pilot study on biological and psychosocial parameters of overweight and obese breast cancer survivors. Pilot and feasibility studies 2018;4(1)  https://doi.org/10.1186/s40814-017-0160-9

  38. Stolley M, Sheean P, Gerber B et al (2017) Efficacy of a weight loss intervention for African American breast cancer survivors. J Clin Oncol 35(24):2820–2828. https://doi.org/10.1200/JCO.2016.71.9856

    Article  PubMed  PubMed Central  Google Scholar 

  39. Reeves M, Winkler E, McCarthy N et al (2017) The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer. Asia Pac J Clin Oncol 13(3):125–136. https://doi.org/10.1111/ajco.12629

    Article  PubMed  Google Scholar 

  40. Santa-Maria CA, Coughlin JW, Sharma D et al (2020) The effects of a remote based weight loss program on adipocytokines, metabolic markers, and telomere length in breast cancer survivors: the POWER-Remote Trial. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-2935

    Article  PubMed  PubMed Central  Google Scholar 

  41. Harrigan M, Cartmel B, Loftfield E et al (2016) Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study. J Clin Oncol 34(7):669–676. https://doi.org/10.1200/JCO.2015.61.6375

    Article  PubMed  Google Scholar 

  42. Greenlee HA, Crew KD, Mata JM et al (2013) A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obesity (silver spring, md) 21(1):65–76. https://doi.org/10.1002/oby.20245

    Article  CAS  Google Scholar 

  43. Raji Lahiji M, Najafi S, Janani L, et al. The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: a randomized, triple-blind, controlled trial. Clinical nutrition (Edinburgh, Scotland) 2020 https://doi.org/10.1016/j.clnu.2020.05.043

  44. Thomson CA, Stopeck AT, Bea JW, et al. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutrition and cancer 2010;62(8):1142‐52.  https://doi.org/10.1080/01635581.2010.513803

  45. Anderson C, Harrigan M, George SM et al (2016) Changes in diet quality in a randomized weight loss trial in breast cancer survivors: the lifestyle, exercise, and nutrition (LEAN) study. NPJ Breast Cancer 2:16026. https://doi.org/10.1038/npjbcancer.2016.26

    Article  PubMed  PubMed Central  Google Scholar 

  46. Chan DSM, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25(10):1901–1914. https://doi.org/10.1093/annonc/mdu042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34(6):611–635. https://doi.org/10.1200/jco.2015.64.3809

    Article  CAS  PubMed  Google Scholar 

  48. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627–635. https://doi.org/10.1007/s10549-010-0990-0

    Article  PubMed  Google Scholar 

  49. Niraula S, Ocana A, Ennis M, Goodwin PJ (2012) Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 134(2):769–781. https://doi.org/10.1007/s10549-012-2073-x

    Article  CAS  PubMed  Google Scholar 

  50. Kwan ML, John EM, Caan BJ et al (2014) Obesity and mortality after breast cancer by race/ethnicity: the California Breast Cancer Survivorship Consortium. Am J Epidemiol 179(1):95–111. https://doi.org/10.1093/aje/kwt233

    Article  PubMed  Google Scholar 

  51. Arias Téllez MJ, Acosta FM, Sanchez-Delgado G, et al. Association of neck circumference with anthropometric indicators and body composition measured by DXA in young Spanish adults. Nutrients. 2020;12(2). https://doi.org/10.3390/nu12020514.

  52. Dunkley AJ, Charles K, Gray LJ et al (2012) Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab 14(7):616–625. https://doi.org/10.1111/j.1463-1326.2012.01571.x

    Article  CAS  PubMed  Google Scholar 

  53. Wieland LS, Falzon L, Sciamanna CN, et al. Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people. Cochrane Database Syst Rev. 2012;8(8):Cd007675.  https://doi.org/10.1002/14651858.CD007675.pub2.

  54. Physical Activity Guidelines Advisory Committee (2008) Physical Activity Guidelines Advisory Committee report, 2008. US Department of Health and Human Services, Washington, DC

    Google Scholar 

  55. McTiernan, Anne. “Obesity and cancer: the risks, science, and potential management strategies.” Oncology (Williston Park, N.Y.) vol. 19,7 (2005): 871–81; discussion 881–2, 885–6.

  56. Byers T, Sedjo RL (2011) Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13(12):1063–1072. https://doi.org/10.1111/j.1463-1326.2011.01464.x

    Article  CAS  PubMed  Google Scholar 

  57. Albuquerque KV, Price MR, Badley RA et al (1995) Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol 21(5):504–509. https://doi.org/10.1016/s0748-7983(95)96935-7

    Article  CAS  PubMed  Google Scholar 

  58. Al Murri AM, Bartlett JM, Canney PA et al (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227–230. https://doi.org/10.1038/sj.bjc.6602922

    Article  CAS  PubMed  Google Scholar 

  59. Potter GD, Skene DJ, Arendt J et al (2016) Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocr Rev 37(6):584–608. https://doi.org/10.1210/er.2016-1083

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Troesch B, Eggersdorfer M, Laviano A, et al. Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition. Nutrients. 2020;12(9):2555. Published 2020 Aug 24.  https://doi.org/10.3390/nu12092555

  61. Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis [published correction appears in Gastric Cancer. 2019 Mar 1;:]. Gastric Cancer. 2019;22(1):10–22. https://doi.org/10.1007/s10120-018-0882-2

  62. Matsunaga T, Miyata H, Sugimura K et al (2019) Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer. Anticancer Res 39(1):449–458. https://doi.org/10.21873/anticanres.13133

    Article  CAS  PubMed  Google Scholar 

  63. Mintziras I, Miligkos M, Wächter S et al (2018) Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis. Int J Surg 59:19–26. https://doi.org/10.1016/j.ijsu.2018.09.014

    Article  PubMed  Google Scholar 

  64. Guest DD, Evans EM, Rogers LQ (2013) Diet components associated with perceived fatigue in breast cancer survivors. Eur J Cancer Care (Engl) 22(1):51–59. https://doi.org/10.1111/j.1365-2354.2012.01368.x

    Article  CAS  Google Scholar 

  65. Knight BB, Oprea-Ilies GM, Nagalingam A et al (2011) Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. Endocr Relat Cancer 18(4):413–428. https://doi.org/10.1530/erc-11-0075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Ballard-Barbash R, Friedenreich CM, Courneya KS et al (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104(11):815–840. https://doi.org/10.1093/jnci/djs207

    Article  PubMed  PubMed Central  Google Scholar 

  67. Löf M, Bergström K, Weiderpass E (2012) Physical activity and biomarkers in breast cancer survivors: a systematic review. Maturitas 73(2):134–142. https://doi.org/10.1016/j.maturitas.2012.07.002

    Article  CAS  PubMed  Google Scholar 

  68. Ma C, Avenell A, Bolland M et al (2017) Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 359:j4849. https://doi.org/10.1136/bmj.j4849

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable

Author information

Authors and Affiliations

Authors

Contributions

The conception and design of the review: Shurui Wang, Ting Yang, Wanmin Qiang, Zihan Zhao, Aomei Shen, Fangyuan Zhang.

Literature retrieval: Shurui Wang, Ting Yang.

Literature screening: Shurui Wang, Ting Yang, Zihan Zhao.

Quality assessment: Shurui Wang, Ting Yang, Zihan Zhao, Aomei Shen.

Data analysis: Shurui Wang, Wanmin Qiang, Aomei Shen, Fangyuan Zhang.

Writing – original draft: Shurui Wang.

Writing – review and editing: Shurui Wang, Ting Yang, Wanmin Qiang, Zihan Zhao, Aomei Shen, Fangyuan Zhang.

All authors read and approved the manuscript.

Corresponding author

Correspondence to Wanmin Qiang.

Ethics declarations

Ethics approval and consent to participate

Not applicable. As this is a systematic review reporting on existing data, ethics approval was not required.

Consent for publication

All authors read and approved the manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 6104 KB)

Supplementary file2 (DOCX 29 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, S., Yang, T., Qiang, W. et al. Benefits of weight loss programs for breast cancer survivors: a systematic reviews and meta-analysis of randomized controlled trials. Support Care Cancer 30, 3745–3760 (2022). https://doi.org/10.1007/s00520-021-06739-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-021-06739-z

Keywords

Navigation